JP2020521470A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020521470A5 JP2020521470A5 JP2019565334A JP2019565334A JP2020521470A5 JP 2020521470 A5 JP2020521470 A5 JP 2020521470A5 JP 2019565334 A JP2019565334 A JP 2019565334A JP 2019565334 A JP2019565334 A JP 2019565334A JP 2020521470 A5 JP2020521470 A5 JP 2020521470A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- seq
- deletion
- recombinant adenovirus
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023037694A JP2023063392A (ja) | 2017-05-24 | 2023-03-10 | 抗脈管形成アデノウイルス |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762510647P | 2017-05-24 | 2017-05-24 | |
| US62/510,647 | 2017-05-24 | ||
| US201762514351P | 2017-06-02 | 2017-06-02 | |
| US62/514,351 | 2017-06-02 | ||
| PCT/US2018/034487 WO2018218083A1 (en) | 2017-05-24 | 2018-05-24 | Anti-angiogenic adenovirus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023037694A Division JP2023063392A (ja) | 2017-05-24 | 2023-03-10 | 抗脈管形成アデノウイルス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020521470A JP2020521470A (ja) | 2020-07-27 |
| JP2020521470A5 true JP2020521470A5 (https=) | 2021-07-26 |
| JP7245175B2 JP7245175B2 (ja) | 2023-03-23 |
Family
ID=64396026
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565334A Active JP7245175B2 (ja) | 2017-05-24 | 2018-05-24 | 抗脈管形成アデノウイルス |
| JP2023037694A Pending JP2023063392A (ja) | 2017-05-24 | 2023-03-10 | 抗脈管形成アデノウイルス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023037694A Pending JP2023063392A (ja) | 2017-05-24 | 2023-03-10 | 抗脈管形成アデノウイルス |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200155625A1 (https=) |
| EP (1) | EP3630959A4 (https=) |
| JP (2) | JP7245175B2 (https=) |
| KR (1) | KR20200020723A (https=) |
| CN (1) | CN111448309A (https=) |
| AU (1) | AU2018271999A1 (https=) |
| CA (1) | CA3064892A1 (https=) |
| MX (1) | MX2019014059A (https=) |
| WO (1) | WO2018218083A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| KR102608590B1 (ko) | 2014-09-24 | 2023-12-01 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 종양 살상 바이러스 및 이의 사용방법 |
| WO2017147269A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| EP3532082A4 (en) | 2016-12-12 | 2020-08-26 | Salk Institute for Biological Studies | SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES |
| EA201990822A1 (ru) | 2017-04-12 | 2020-01-09 | Эписентарикс, Инк. | Иммуномодулирующие слитые белки |
| CN112292449A (zh) | 2018-04-09 | 2021-01-29 | 萨克生物研究学院 | 具有增强的复制特性的溶瘤腺病毒组合物 |
| CN110295195A (zh) * | 2019-06-26 | 2019-10-01 | 浙江理工大学 | 靶向肝癌的溶瘤腺病毒gd55-gsdme的构建和应用 |
| WO2021248101A1 (en) * | 2020-06-05 | 2021-12-09 | Epicentrx, Inc. | Mono- and multi-valent sars-cov-2 adenoviral vector vaccines and sars-cov-2 immune globulin and methods of use |
| CN115120744B (zh) * | 2021-03-24 | 2025-01-28 | 四川大学 | 重组人内皮抑素腺病毒与抗pd-1抗体或抗pd-l1抗体在制备抗肿瘤药物中的用途 |
| CN114931634B (zh) * | 2022-03-18 | 2023-03-17 | 广州达博生物制品有限公司 | E10a与pd1单抗对肿瘤的联合治疗方法和制药用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1183250C (zh) * | 2000-12-01 | 2005-01-05 | 卫健生物科技有限公司 | 高效表达肿瘤血管生成抑制因子的肿瘤细胞内特异性增殖的病毒及其构建方法 |
| AU2002256388A1 (en) * | 2001-04-30 | 2002-11-11 | Cell Genesys, Inc. | Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteins |
| US20050136035A1 (en) * | 2003-06-03 | 2005-06-23 | Derek Ko | Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| SG158133A1 (en) * | 2004-12-31 | 2010-01-29 | Sonne Holm | Method for reversing multiple resistance in animal cells |
| KR100896483B1 (ko) * | 2007-07-13 | 2009-05-08 | 연세대학교 산학협력단 | Ｉｌ-12 및 4-1ｂｂｌ을 발현하는 종양 선택적 살상 재조합아데노바이러스 및 수지상 세포를 유효성분으로 포함하는항종양용 약제학적 조성물 |
| HUE026386T2 (en) * | 2009-03-02 | 2016-06-28 | Univ California | Tumor-selective adenovirus e1a and e1b mutants |
| CA3052090A1 (en) * | 2017-01-30 | 2018-08-02 | Epicentrx, Inc. | Multiple transgene recombinant adenovirus |
-
2018
- 2018-05-24 US US16/616,146 patent/US20200155625A1/en not_active Abandoned
- 2018-05-24 MX MX2019014059A patent/MX2019014059A/es unknown
- 2018-05-24 KR KR1020197037967A patent/KR20200020723A/ko not_active Ceased
- 2018-05-24 EP EP18806701.1A patent/EP3630959A4/en not_active Withdrawn
- 2018-05-24 CA CA3064892A patent/CA3064892A1/en active Pending
- 2018-05-24 JP JP2019565334A patent/JP7245175B2/ja active Active
- 2018-05-24 AU AU2018271999A patent/AU2018271999A1/en not_active Abandoned
- 2018-05-24 WO PCT/US2018/034487 patent/WO2018218083A1/en not_active Ceased
- 2018-05-24 CN CN201880051792.1A patent/CN111448309A/zh active Pending
-
2023
- 2023-03-10 JP JP2023037694A patent/JP2023063392A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020521470A5 (https=) | ||
| JP2022501339A5 (https=) | ||
| Coccolini et al. | Advanced gastric cancer: what we know and what we still have to learn | |
| Seifert et al. | Radiation therapy induces macrophages to suppress T-cell responses against pancreatic tumors in mice | |
| Vici et al. | Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies | |
| Piper et al. | Glioma stem cells as immunotherapeutic targets: advancements and challenges | |
| Sideras et al. | Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies | |
| Yang et al. | Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy | |
| Amedei et al. | Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy | |
| JP7245175B2 (ja) | 抗脈管形成アデノウイルス | |
| JP2020516293A5 (https=) | ||
| JP2016528195A5 (https=) | ||
| JP2020505049A5 (https=) | ||
| CN111050790B (zh) | 通过静脉内施用重组mva和抗体治疗癌症的组合疗法 | |
| JP2020510624A5 (https=) | ||
| RU2019136640A (ru) | Композиции с улучшенными т-клетками и способы | |
| AU2021203142B2 (en) | Anticancer Composition Comprising Recombinant Adenovirus Expressing Degradation Factor For Extracellular Matrix | |
| JP2016537417A (ja) | 腫瘍抗原を発現するポックスウイルスならびに免疫チェックポイント阻害剤のアンタゴニスト及び／またはアゴニストにより癌を治療するための組み合わせ療法 | |
| JP2015506704A5 (https=) | ||
| Wojtowicz et al. | Immunologic approaches to cancer prevention—current status, challenges, and future perspectives | |
| JP2020517261A5 (https=) | ||
| WO2019109838A1 (zh) | 编码car的核苷酸序列、表达该car的robo1 car-nk细胞及其制备和应用 | |
| Tu et al. | Advances in immunotherapy for gynecological malignancies | |
| CN110248671A (zh) | 包含溶瘤痘病毒和nk细胞的治疗剂及其在治疗肿瘤和/或癌症的药物中的应用 | |
| JP2018526453A5 (https=) |